gadolinium dtpa has been researched along with Hypophosphatemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bulsara, K; Chen, D; Dhib-Jalbut, S; Imitola, J; Malchoff, C; Wolansky, I; Wolansky, L; Wu, R | 1 |
| Bageac, D; DeBevits, JJ; Dhib-Jalbut, S; DiCamillo, PA; Hu, C; Kaplan, J; Karimeddini, D; Munbodh, R; Naismith, RT; Wang, Y; Wolansky, L; Wu, R | 1 |
2 other study(ies) available for gadolinium dtpa and Hypophosphatemia
| Article | Year |
|---|---|
Monthly triple-dose gadolinium administration: potential associations with leukopenia, hypophosphatemia, and bone marrow T1 hyperintensity.
Topics: Bone Marrow; Cerebellar Nuclei; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Hypophosphatemia; Leukopenia; Magnetic Resonance Imaging; Organometallic Compounds; Retrospective Studies; Skull | 2022 |
MRI demonstration of gadolinium deposition in bone after monthly triple-dose gadopentetate dimeglumine and correlation with frequency of hypophosphatemia.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Hypophosphatemia; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies | 2021 |